MedTrace Logo

Small Coronary Artery Treated by TAXUS Liberté Registry in Japan

NCT00955214 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2010-06-10

No results posted yet for this study

Summary

The utilization of paclitaxel-eluting coronary stents in small vessel diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of the Taxus Liberte™ Paclitaxel-Eluting Coronary Stent in small coronary arteries of ≤ 2.5 mm in the reference vessel diameter.

Conditions

  • Stable Angina Pectoris
  • Unstable Angina Pectoris

Interventions

DEVICE

TAXUS Liberté paclitaxel-eluting coronary stent system

diameter is 2.5mm

Sponsors & Collaborators

  • Society for Advancement of Coronary Intervention Research

    lead NETWORK

Principal Investigators

  • Kenya Nasu, MD · Toyohashi Heart Center

  • Yuji Oikawa, MD · Cardiovascular institute hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-08-31
Completion
2012-08-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00955214 on ClinicalTrials.gov